CRISPR 2.0, the Next Generation

History was made this year when the first FDA-approved CRISPR-based gene editing therapy became available to patients, designed to cure sickle cell anemia. That represents ground-breaking progress, but the treatment involves a months-long ordeal with often-brutal side effects and it is hugely expensive. With dozens of CRISPR therapeutics in the second phase of human trials, hopes run high that next-generation approaches will be easier and cheaper to deliver and more patient friendly. The payoff could be major progress in treating blood disorders, cardiovascular disease, cancer, and infectious diseases.

Aspen Ideas: Health takes place on the Aspen Institute’s wondrous 40-acre campus in the Rocky Mountains from June 20-23, 2024. The three-day event, which has opened the renowned Aspen Ideas Festival since 2014, is where
health’s biggest challenges meet its biggest thinkers. #AspenIdeasHealth #AspenIdeas

For more information about Aspen Ideas: Health, visit https://www.aspenideas.org/attend/health.